Dr. Rajan Avinash Kadakia, MD

Dr. Kadakia practices at Rajan Kadakia, M.D. P.A. in Houston, Texas.

Dr. Kadakia's NPI, 1548295264, was assigned on July 11, 2006. Dr. Kadakia graduated from VCU School of Medicine in 2001. Dr. Kadakia holds Texas license L4998.

Dr. Kadakia's primary practice is Rajan Kadakia, M.D. P.A., at 11920 Astoria Blvd, Houston, TX 77089 in Harris County. The practice phone is (281) 506-8720.

Dr. Kadakia's primary practice is Rajan Kadakia, M.D. P.A. in Houston, Texas. Dr. Kadakia is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is CPF Cardiology Associates, P.A. Dmand AI also links Dr. Kadakia to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadakia practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kadakia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kadakia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Kadakia is licensed in Texas.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Kadakia treats.

CMS data shows 4,416 Medicare services from Dr. Kadakia across 28 procedure codes in 2024, for 486 Medicare patients. Medicare paid $513,030 for them.

CMS counts 486 Medicare patients who saw Dr. Kadakia in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadakia's median patient age at 72, with 51% women.

In 2024, Dr. Kadakia wrote 6,786 Medicare Part D claims for 820 patients. 87% of them were for generic drugs. CMS names the drug for 6,495 of them, across 59 drugs with 11 or more claims each, at $1,091,584 in total drug cost. In 2023, CMS named 6,098 claims across 53 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kadakia for performance year 2024, reported as part of a group. Dr. Kadakia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadakia as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Kadakia. The most frequent topics are Angioplasty, Balloon, Coronary. Dr. Kadakia's most frequent co-authors are Rupin A. Kadakia, MD and Peter Andrew McCullough, MD, MPH.

CMS Open Payments shows 240 general payments to Dr. Kadakia from 29 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 62% of the total. Medtronic Vascular, Inc. paid the most, $13,665.

Dmand AI lists 1 award for Dr. Kadakia, most recently CMS Stage 1 EHR in 2012.

Dr. Kadakia graduated from VCU School of Medicine in 2001. Dr. Kadakia is a member of ACC.

Dr. Kadakia is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.